Skip to main content

hsCRP Can ID Cardiovascular Risk in Women Without Modifiable Risk Factors

Medically reviewed by Carmen Pope, BPharm. Last updated on Sep 8, 2025.

via HealthDay

MONDAY, Sept. 8, 2025 -- High levels of high-sensitivity C-reactive protein (hsCRP) can identify cardiovascular risk among women who do not have any of the four standard modifiable cardiovascular risk factors (SMuRFs): hypertension, dyslipidemia, diabetes mellitus, and smoking, according to a study published online Aug. 29 in the European Heart Journal.

Paul M. Ridker, M.D., M.P.H., from Harvard Medical School in Boston, and colleagues examined the utility of hsCRP to detect cardiovascular risk in SMuRF-less women. hsCRP was measured at baseline among 12,530 initially healthy American women who were followed for first major adverse cardiovascular events (MACEs) over 30 years.

The researchers found that 973 first MACEs were accrued during 30-year follow-up. SMuRF-less women who subsequently suffered a cardiovascular event had significantly higher median baseline hsCRP than those who did not (median, 2.22 versus 1.50 mg/L). The hazard ratios for the primary end point of incident coronary heart disease (CHD) were 1.0 (referent), 1.24 (95 percent confidence interval [CI], 0.89 to 1.74), 1.41 (95 percent CI, 1.02 to 1.96), 1.57 (95 percent CI, 1.14 to 2.16), and 2.23 (95 percent CI, 1.65 to 3.03) for the lowest to highest levels of hsCRP at study entry in age-adjusted analyses; for each increasing quintile of hsCRP, CHD risk increased 21 percent over 30 years. Compared with those with hsCRP <1 mg/L, SMuRF-less women with hsCRP >3 mg/L had a 77, 39, and 52 percent higher risk for CHD events, ischemic stroke events, and total cardiovascular disease events, respectively.

"Our data clearly show that apparently healthy women who are inflamed are at substantial lifetime risk. We should be identifying these women in their 40s, at a time when they can initiate preventive care," Ridker said in a statement.

Several authors disclosed ties to relevant organizations.

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2025 HealthDay. All rights reserved.

Read this next

Nonoptimal Levels of Traditional Risk Factors Almost Universal Before CVD

MONDAY, Sept. 29, 2025 -- Almost all adults have nonoptimal levels of one or more traditional risk factors before being diagnosed with cardiovascular disease (CVD), according to a...

Prevention Strategies Developed for Cardiovascular Manifestations of COVID

FRIDAY, Sept. 26, 2025 -- Prevention strategies for cardiovascular manifestations of acute and long COVID are discussed in a report published online Sept. 18 in the European...

Cocoa Extract Supplementation Yields Significant Reduction in hsCRP

WEDNESDAY, Sept. 24, 2025 -- Cocoa extract supplementation yields a significant reduction in high-sensitivity C-reactive protein (hsCRP) and an increase in interferon-&gamma...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.